Global Cell Therapy Manufacturing Market Growth (Status and Outlook) 2023-2029

Global Cell Therapy Manufacturing Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “Cell Therapy Manufacturing Industry Forecast” looks at past sales and reviews total world Cell Therapy Manufacturing sales in 2022, providing a comprehensive analysis by region and market sector of projected Cell Therapy Manufacturing sales for 2023 through 2029. With Cell Therapy Manufacturing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Therapy Manufacturing industry.

This Insight Report provides a comprehensive analysis of the global Cell Therapy Manufacturing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell Therapy Manufacturing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Therapy Manufacturing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Therapy Manufacturing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Therapy Manufacturing.

The global Cell Therapy Manufacturing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Cell Therapy Manufacturing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Cell Therapy Manufacturing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Cell Therapy Manufacturing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Cell Therapy Manufacturing players cover Merck, Avantor, Cell Therapies, Thermo Fisher Scientific, Charles River Laboratories, Catalent, Bio-Techne, Cytiva and Lonza, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Cell Therapy Manufacturing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Autologous
Allogenic

Segmentation by application
Clinical
Commercial
Pre-clinical

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
Avantor
Cell Therapies
Thermo Fisher Scientific
Charles River Laboratories
Catalent
Bio-Techne
Cytiva
Lonza
BIOCENTRIQ
FUJIFILM Diosynth Biotechnologies
Novartis
Bristol-Myers Squibb
Gilead
WuXi AppTec
Pharmaron
Aldevron
Exothera

Please note: The report will take approximately 2 business days to prepare and deliver.